Secretory-IgA Antibodies Play an Important Role in the Immunity to Streptococcus pneumoniae

被引:71
作者
Fukuyama, Yoshiko [1 ]
King, Janice D. [2 ]
Kataoka, Kosuke [3 ]
Kobayashi, Ryoki [1 ]
Gilbert, Rebekah S. [2 ]
Oishi, Kazunori [4 ]
Hollingshead, Susan K. [2 ]
Briles, David E. [2 ]
Fujihashi, Kohtaro [1 ,2 ]
机构
[1] Univ Alabama Birmingham, Inst Oral Hlth Res, Immunobiol Vaccine Ctr, Dept Pediat Dent, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA
[3] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Prevent Dent, Tokushima 770, Japan
[4] Osaka Univ, Microbial Dis Res Inst, Int Res Ctr Infect Dis, Lab Clin Res Infect Dis, Osaka, Japan
基金
日本学术振兴会; 美国国家卫生研究院;
关键词
SURFACE PROTEIN-A; PNEUMOCOCCAL CONJUGATE VACCINE; FLT3 LIGAND CDNA; MUCOSAL IMMUNITY; INTRANASAL IMMUNIZATION; ORAL VACCINATION; NASOPHARYNGEAL CARRIAGE; LYMPHORETICULAR TISSUE; PULMONARY INFECTION; PROTECTIVE MUCOSAL;
D O I
10.4049/jimmunol.1000831
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This study was designed to investigate whether secretory-IgA (S-IgA) Abs induced by a pneumococcal surface protein A(PspA)-based nasal vaccine are necessary for prevention of streptococcal colonization. Mice nasally immunized with PspA plus a plasmid expressing Flt3 ligand (pFL) cDNA as a mucosal adjuvant showed significantly higher levels of PspA-specific S-IgA and IgG Ab responses in both plasma and nasal washes when compared with naive mice. Although IgA(-/-) mice given nasal PspA plus pFL had significantly high levels of PspA-specific IgG Abs, high numbers of CFUs were detected in nasal washes and nasal passages. In contrast, vaccinated wild-type mice showed essentially no bacteria in the nasal cavity. Further, a nasal vaccine consisting of PspA plus pFL effectively reduced pre-existing Streptococcus pneumoniae in the nasal cavity. These results show that PspA-based vaccine-induced specific S-IgA Abs play a necessary role in the regulation of S. pneumoniae colonization in the nasal cavity. The Journal of Immunology, 2010, 185: 1755-1762.
引用
收藏
页码:1755 / 1762
页数:8
相关论文
共 48 条
  • [1] Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection
    Arulanandam, BP
    Lynch, JM
    Briles, DE
    Hollingshead, S
    Metzger, DW
    [J]. INFECTION AND IMMUNITY, 2001, 69 (11) : 6718 - 6724
  • [2] Treatment of community-acquired pneumonia - IDSA guidelines
    Bernstein, JM
    [J]. CHEST, 1999, 115 (03) : 9S - 13S
  • [3] Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
    Black, S
    Shinefield, H
    Fireman, B
    Lewis, E
    Ray, P
    Hansen, JR
    Elvin, L
    Ensor, KM
    Hackell, J
    Siber, G
    Malinoski, F
    Madore, D
    Chang, I
    Kohberger, R
    Watson, W
    Austrian, R
    Edwards, K
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) : 187 - 195
  • [4] Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae
    Briles, DE
    Ades, E
    Paton, JC
    Sampson, JS
    Carlone, GM
    Huebner, RC
    Virolainen, A
    Swiatlo, E
    Hollingshead, SK
    [J]. INFECTION AND IMMUNITY, 2000, 68 (02) : 796 - 800
  • [5] Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae
    Briles, DE
    Hollingshead, SK
    Paton, JC
    Ades, EW
    Novak, L
    van Ginkel, FW
    Benjamin, WH
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (03) : 339 - 348
  • [6] STRONG ASSOCIATION BETWEEN CAPSULAR TYPE AND VIRULENCE FOR MICE AMONG HUMAN ISOLATES OF STREPTOCOCCUS-PNEUMONIAE
    BRILES, DE
    CRAIN, MJ
    GRAY, BM
    FORMAN, C
    YOTHER, J
    [J]. INFECTION AND IMMUNITY, 1992, 60 (01) : 111 - 116
  • [7] Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA
    Briles, DE
    Hollingshead, SK
    King, J
    Swift, A
    Braun, PA
    Park, MK
    Ferguson, LM
    Nahm, MH
    Nabors, GS
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (06) : 1694 - 1701
  • [8] Crottet P, 1998, J IMMUNOL, V161, P5445
  • [9] Characterization of Protective Mucosal and Systemic Immune Responses Elicited by Pneumococcal Surface Protein PspA and PspC Nasal Vaccines against a Respiratory Pneumococcal Challenge in Mice
    Ferreira, D. M.
    Darrieux, M.
    Silva, D. A.
    Leite, L. C. C.
    Ferreira, J. M. C., Jr.
    Ho, P. L.
    Miyaji, E. N.
    Oliveira, M. L. S.
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2009, 16 (05) : 636 - 645
  • [10] Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production
    Ferreira, Daniela M.
    Darrieux, Michelle
    Oliveira, Maria Leonor S.
    Leite, Luciana C. C.
    Miyaji, Eliane N.
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2008, 15 (03) : 499 - 505